Abstract | BACKGROUND: The efficacy of single daily dose of amikacin has been recently demonstrated in neutropenic children with fever. POPULATION AND METHODS: Eighteen children aged 1 to 15 years were included in the study. All patients were febrile and granulocytopenic and had indwelling intravenous catheter. Amikacin was administered as a 30-minute intravenous infusion once daily (20 mg/kg on day 1, then 15 mg/kg) for 3 to 30 days; the patients received amikacin in combination with piperacillin and vancomycin. Serum levels of amikacin were measured on days 1, 3, 6 and 10, and 30 min, 60 min and 180 min after the end of the infusion. RESULTS: All patients responded favourably to the antibiotic therapy. Sixty-two kinetics were performed: peak amikacin concentrations measured (30 min after 30-min infusion) on day 1 averaged 43.7 micrograms/mL (+/- 13.8). A significant increase in peak serum concentrations was observed during the treatment (day 3 vs day 10) without change in the trough serum concentrations. The volumes of distribution were considerably important in these granulocytopenic children and there was a large inter and intra-patient variability; the elimination half-life of the amikacin was short (1.45 h). There was no significant nephrotoxicity in any patient. CONCLUSION: The use of single daily dose amikacin in combination with a broad spectrum beta-lactam antibiotic and vancomycin was efficient and safe in febrile granulocytopenic children. The simulation of the amikacin behaviour in the deep compartment should be evaluated; in fact, it might reflect better accumulation of the drug than serum concentrations.
|
Authors | Y Bertrand, V Bréant, C Vray, C Nakache, G Barbé, F Dürr, G Aulagner |
Journal | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
(Arch Pediatr)
Vol. 3
Issue 9
Pg. 854-60
(Sep 1996)
ISSN: 0929-693X [Print] France |
Vernacular Title | Etude clinique, pharmacocinétique et thérapeutique de l'amikacine en dose unique journalière et en association chez l'enfant neutropénique fébrile. |
PMID | 8949344
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Penicillins
- Vancomycin
- Amikacin
- Piperacillin
|
Topics |
- Adolescent
- Amikacin
(administration & dosage, blood, pharmacokinetics, therapeutic use)
- Anti-Bacterial Agents
(administration & dosage, blood, pharmacokinetics, therapeutic use)
- Child
- Child, Preschool
- Drug Therapy, Combination
- Fever
(complications)
- Humans
- Infant
- Neutropenia
(complications, drug therapy)
- Penicillins
(administration & dosage, therapeutic use)
- Piperacillin
(administration & dosage, therapeutic use)
- Vancomycin
(administration & dosage, therapeutic use)
|